Page 1,537«..1020..1,5361,5371,5381,539..1,5501,560..»

Walk for "terrible, awful" disease – Timmins Press

Posted: June 18, 2017 at 8:43 pm

TIMMINS-

It seemed that everyone at this year's ALS walk had a personal connection to the disease.

Either the story was written in one word, a fill-in-the-blank sticker on walkers' shirts stating the name of the person they walked for a father, a sister, a grandparent or a friend, or it was told in conversation with other participants who could relate.

Saturday's walk was dedicated to three Timmins women currently living with ALS Janine, Gloria and Joanne.

May Caissy walked for her late husband, Jean-Yves.

My husband passed away three years ago, and I did everything to beat the disease, said Caissy, who said she's now writing a book about her experience.

Within two months of her husband's diagnosis, he was no longer able to work. And like other people diagnosed with ALS, he lost one ability after another.

It started with constant twitches and spasms and ended with her husband no longer able to communicate.

I took him to Alabama for stem cells. I read from day to night to try to find any kind of cure, any kind of food that would change the process.

Caissy joked that she may not be a doctor, but after all her research, she feels like a scientist.

She wore purple to the walk, bringing purple balloons to share with other participants. She said there's some irony in the fact that purple was her wedding colour and is also the colour for the walk.

Siblings Dominique and David Cadeau walked for seven family members who had ALS: their brother, mother, grandfather, two aunts and two uncles.

It's an awful disease, said David Cadeau. The last few years, at the walks were just people who've been affected.

He's hopeful that a cure will be found one day.

We actually started the ALS walk here in Timmins, it was in memory of my brother Durwin, said Dominique Cadeau.

That was more than a decade ago but the family still comes to the fundraising event, now organized by the ALS Society of Canada.

Brigitte Labby is the regional manager for North East Ontario. She said the goal for the day was $8,000 60% of which would be used for client services, which includes client support, our equipment program, education and awareness.

The rest would be used to research the disease, also known as amyotrophic lateral sclerosis, or Lou Gehrig's Disease.

Things are coming along. We're starting to understand what may or may not be causing it, so it's still quite critical, said Labby.

An individual will lose their ability to use their limbs, will lose muscle mass, and eventually won't be able to stand or walk, and eventually will have difficulties speaking and eating, said said, noting that the disease is a terminal one.

She said she has 46 ALS clients in the region, though there are about 860 in the province. Labby will participate in several fundraising walks this spring. Recently, Sault Ste. Marie and Sudbury walks raised $59,000 and nearly $30,000 respectively.

Luckily, Labby chose cole secondaire Thriault instead of Gillies Lake for the walk. With rain pouring down for much of the morning, the event was held inside the year.

The organizer handed out cornflower seeds to families of people with ALS, noting the flowers are both hardy and delicate just like ALS patients.

NDP MPP Gilles Bisson (Timmins-James Bay) attended the event and told the crowd, We live with hope for the day that we're going to be able to make breakthroughs for the disease so that we can actually fight this and we can win the fight against ALS.

City of Timmins mayor Steve Black thanked volunteers and fundraisers, but said recognition was due to those who care for loved ones with ALS.

I know it means the world to them, Black said. A big congratulations...for the support that you give, day in and day out, dealing with this terrible disease.

Read more:
Walk for "terrible, awful" disease - Timmins Press

Posted in Alabama Stem Cells | Comments Off on Walk for "terrible, awful" disease – Timmins Press

Rare disease hits 2 of family’s 4 children – The Ledger

Posted: June 18, 2017 at 8:43 pm

The children have a debilitating metabolic disorder that affects only 500 people in the United States.

LAKELAND Joel Strickland is a rare boy, not only because he is a diminutive, 12-year-old, guitar-playing, cowboy-hat-wearing, dirt-bike-riding fisherman and hunter whose love of cooking has led to being an online Tupperware salesman.

He is rare because he does all this while dealing with a debilitating metabolic disorder that affects only 500 people in the United States.

Both Joel and his 1-year-old sister, Hannah, have been diagnosed with the genetic disorder cystinosis.

Their parents, Dawn and Travis Strickland, ages 38 and 44, of Lakeland, did not know they each carry a recessive gene for cystinosis, a disease so atypical that only 2,500 people worldwide are diagnosed with it and so serious that the good news is some patients are now surviving into their late 20s, even 30s and early 40s.

Their son Jonah, 14, and daughter Grace, 7, did not inherit the disorder.

In cystinosis the body accumulates the amino acid cystine (a building block of proteins), according to the National Institutes of Healths Genetic and Rare Disease Information Center. The extra cystine forms crystals that can build up and damage cells, which can impact all the organs.

Those diagnosed with the disorder must remain on a strict regimen of medications and supplements to prevent complications, including kidney failure, blindness, muscle wasting, difficulty swallowing, diabetes and hypothyroidism.

All cystinosis patients are very different, said Dr. Carlos Araya, a pediatrician and pediatric nephrologist with Nemours Childrens Hospital in Orlando, who said he has treated only four children with cystinosis, including Joel and Hannah.

Even Joel and Hannah, who have the same genetic marker, seem to be presenting differently, Araya said.

Joel had iron, potassium and bicarbonate deficiencies so severe that by the time he was 18 months old he had developed rickets, a sign of severe malnutrition. His frequent vomiting prevented his body from absorbing nutrients so his muscles were not developing and he was weak, not yet walking, his mother said.

Hannah has phosphorous and bicarbonate deficiencies. She does not have the severe vomiting issues Joel had at her age, but she is underweight, only 14 pounds.

Since being hospitalized for nearly a week in January she had developed cystinosis-related severe dehydration she reverted from eating solid food, her mother said. And it has been increasingly difficult to get her to take a bottle. She wants only water so she is not getting her needed nutrition.

Soon, Hannah, like Joel, will have a feeding tube, which requires a surgical procedure.

When Joels feeding tube was inserted a decade ago, he was receiving both food and medications through it. Now it is for medications only and, his mother said, Joel is an adventurous eater, always looking for something new and exotic to try after the nausea passes from the twice-a-day dose of a maintenance drug that protects his kidneys.

Joel remains small for his age, but he recently completed growth-hormone treatment to help him reach adult height, Araya said.

In addition to Araya, the children see other specialists at Nemours, including a pediatric gastroenterologist and, for Joel, a pediatric endocrinologist. And Nemours has a pediatric ophthalmologist who makes visits to Lakeland, and through him, Joel obtains his eye drops, which much be administered once every hour while he is awake, Dawn Strickland said.

Typically the crystals start forming in the eyes at 18 to 24 months so Hannah may soon also be on a schedule of hourly eye drops.

Life expectancy has improved with treatment, Araya said. Having very good adherence to treatment prevents or delays onset of other conditions.

Although kidney failure can still happen, the medication delays it, he said.

The diagnosis

We had never heard of cystinosis when Jonah was a baby, Dawn Strickland said.

When Joel was born, the Stricklands were starting a retail baby-supplies business in their hometown of Crestview.

Even though they often gave advice to other parents, I kept asking people who would come in to look at my baby, He cries a lot; he is little; he does not take his bottle," Dawn Strickland said. "But people would say, He will be OK, you know what you are doing, look at Jonah.

At 4 months, Joel was having trouble taking a bottle, she said. An ear, nose and throat doctorclipped the base of his tongue to see if that would help with his swallowing. Still, Joel could not finish a bottle and he was constantly crying.

At 11 months, he was often vomiting.

By 17 months, the vomiting was every morning; he wanted water and salty foods. He wasnt walking yet.

They kept labeling him with failure to thrive, a very vague diagnosis, Strickland said. Sometimes hed vomit 10 or 15 times a day. They kept saying maybe he will get over it. I knew there was something serious going on.

The Stricklands changed pediatricians. The new pediatrician hospitalized Joel for two weeks and ran a range of tests ruling out cystic fibrosis, cerebral palsy, celiac disease and other disorders and diseases but still came up with no diagnosis other than low sodium and low potassium.

The family asked to go to a larger hospital so Joel was sent to the University of Alabama at Birmingham, four hours away.

Still no diagnosis. But a feeding tube was inserted so Joel was finally getting vital nutrition and was keeping medications down.

Finding an answer

Travis Stricklands parents were living in Tennessee at the time and his mother suggested they take Joel to Vanderbilt University Medical Center.

After being told the next available appointment with a pediatric nephrologist was three months away, the desperate family, afraid Joel would not survive that long, went to Nashville and parked themselves in Vanderbilts emergency department.

I refused to be sent away, and said 'I will keep coming back until someone sees him,' Dawn Strickland said. I told them 'my baby is sick; no one will help me.'

They got an appointment for the following Monday.

The doctor looked through Joels chart, took one look at Joel and said, Have you heard of cystinosis? Dawn Strickland said. I said Id already asked doctors about it and they had said no.

The nephrologist explained that the only way to tell was through a specialized blood test to check for cystine in the cells and to do an eye exam looking for an accumulation of crystals in the eyes.

They had an ophthalmologist check Joels eyes and he immediately saw the crystals at the back of his corneas, Dawn Strickland said. It wastwo weeks before confirmation of cystinosis came through the results of the specialized blood test.

Even a decade later, the memory of that time frustrates Dawn Strickland.

At the beginning

When Joel was about 1 year old, Travis Stricklandcame across a contractor who said he knew of a child with similar symptoms. He couldnt remember the name of the disease but came back a few days later with cystinosis scrawled on a sheet of paper.

Later the same week, three separate friends called Dawn Strickland, each saying they had seen a show on TLC called Mysterious Diagnosis and the symptoms of the disease, cystinosis, sounded like Joels.

I did research on the internet and when I saw the information on cystinosis I just cried and cried. I knew, this was the answer. But when she asked the specialists about cystinosis, they basically said, Dont go on Google, it will scare you. Just go home, mom, you are not a doctor.

At least a year passed before the diagnosis was made and Joel was started on the life-saving medications.

It was devastating to have lost so much time that we could have been administering meds and to know you lost that time because no one was hearing your voice, his mother said.

Grace was born healthy and never developed symptoms.

Hannah also seemed healthy but Dawn Strickland said she asked for Hannah to be tested at 4 months old because she was small and having some difficulty with feeding. When the tests came back positive, medications and supplements started immediately.

The truth of the matter is, I was praying so hard for a diagnosis with Joel. Whatever the diagnosis is, you want to know. Not knowing is the worst thing a person can go through," she said. "I kept praying, God, please give me wisdom.

She said that when Joel was finally diagnosed, I knew God had prepared my heart to start dealing with this.

Coming to Lakeland

The Stricklands arrived in Lakeland about a year ago, movingfrom New Tampa. A guest speaker from Abundant Life Church in Lakeland had intrigued the family and they started traveling to Lakeland for services.

Travis and Dawn Strickland already had a connection although distant to Lakeland. Each had attended Southeastern University at different times in the late 1990s.

Travis went on to receive a degree in mechanical engineering from Troy State. Typically he works on large contract jobs at power plants, which takes him away for months at a time. He currently is looking for work.

Dawn Strickland said, although it is preferable to have both parents available while caring for two chronically ill children who need medications and caretaking around the clock, the family is struggling financially.

She home-schools the children, which allows the family to work around Joels medical condition, to start lessons after daily bouts of pain and nausea pass.

We can do lessons on our schedule, she said.

Joel got interested in Tupperware when his grandmother signed up DawnStricklandto be a Tupperware distributor as a way to earn money. She admitted she was overwhelmed by the prospect, knowing how much time and energy she expends taking care of the family, home-schooling the children and dealing with medical issues.

But Joel was excited, loving to cook and seeing the possibilities,'' she said.He has a video on Facebook that demonstrates how to make an omelet using Tupperware.

Joel saiddealing with all the symptoms and medications probably makes me more determined.

The future

In the decade since Joel was diagnosed, there have been two major advances in treating cystinosis, unusual progress for an orphan disease that is so rare it is not cost-effective for pharmaceutical companies to invest in research.

The progress can be traced to the Cystinosis Research Foundation, founded in 2003 by Nancy and Jeff Stack of Newport Beach, Calif., whose daughter, Natalie, has cystinosis.

There was very little research going on; it was such an ultra-rare disease, Nancy Stack said. We have raised $43 million since 2003. The operations of the foundation are underwritten so all the funds go directly to research.

The money pays for the type of multi-year research projects needed for breakthroughs, Stack said. Currently there are 151 multi-year studies going on across the world.

When Natalie Stack was born 26 years ago, the only medication was in powder form that was mixed into liquid. In 1993-94, the medication became available in pill form, which was administered every six hours.

There was not another breakthrough until 2013, when the foundation-funded slow-release medication, Procysbi, became available.

Taking the medication two times a day instead of four times a day improves the quality of life, Stack said. The side effects are horrific. Now they get them twice a day instead of four times.

And parents, who went for years without a full nights sleep, no longer had to get up in the middle of the night to administer meds, she said.

The foundation also helped fund development of a tiny wafer that will slowly release medication to the eyes, eliminating the need for hourly eye drops that help reduce the painful feeling of sand in the eyes, Stack said. It will become available after it passes through the Food and Drug Administration approval process.

As children reach into their 20s, we see a lot of side effects from having this disease for decades, Stack said. The average age of death is 27 or 28.

At 26, Stacks daughter Natalie is doing remarkably well, although she takes 46 pills a day. She has received her bachelors degree and her masters degree in social work and has a full-time job.

But cystinosis does not go away, her mother said. It is progressive.

A foundation-sponsored researcher has been able to reverse cystinosis in a mouse study using stem cell and gene therapy, Stack said.

We are hoping to get approval to start human trials next year," she said. "We never know what we will get with human patients but we hope at a minimum it could stop cystinosis where it is. At its best, we could reverse damage.

Marilyn Meyer can be reached at marilyn.meyer@theledger.com or 863-802-7558. Follow her on Twitter @marilyn_ledger.

Link:
Rare disease hits 2 of family's 4 children - The Ledger

Posted in Alabama Stem Cells | Comments Off on Rare disease hits 2 of family’s 4 children – The Ledger

Low-cost biochip isolates cells for clinical diagnosis [PreClinical] – 2 Minute Medicine

Posted: June 18, 2017 at 8:42 pm

1. Researchers manufactured a microfluidic biochip, using an inkjet printing system to apply conductive nanoparticles to a polymer substrate.

2. The biochip used an electric field to separate and capture cell populations, allowing for downstream characterization and further analysis.

Evidence Rating Level: 2 (Good)

Study Rundown: Some infectious diseases and cancers can be detected early through the identification of rare cell populations. The sorting and identification of these cells currently require bulky and expensive equipment, preventing their effective use in areas unable to obtain these technologies. The goal of this study was to develop a low-cost, reusable, and effective cell separation platform that could be used for diagnostics in resource-limited areas.

The biochip was designed to have three components: a reusable polyethylene terephthalate substrate with inkjet-printed conductive nanoparticles, a disposable microfluidic platform made of polydimethylsiloxane, and an insulating barrier. The biochip induced dipole moments, resulting in a dielectrophoresis (DEP) force that moved varying cell types based on differences in size and dielectric properties. This allowed for the effective separation and storage of different cell populations. A mixture of breast adenocarcinoma cells, yeast cells, and polystyrene microspheres was used to test the biochip. The three particle types were collected with high separation efficiency. The cells were viable after being on the biochip, indicating they could be used for downstream analyses.

Future work must evaluate the biochip using more clinically relevant cell mixtures. However, the biochip demonstrates potential for diagnostics and research studies on rare cell populations. Without the need for clean rooms or time consuming processing, manufacturing the biochip only requires vector-drawing software and inkjet printing technology. With a production time of around 20 minutes and a materials cost of $0.01 per chip, this biochip could be feasibly produced in developing and low-income areas. Not only can clinical samples be reused after processing on the biochip, but the chip itself is also a reusable platform. This technology could enable faster diagnostic capabilities and early detection of rapidly progressing conditions.

Click here to read the study in PNAS

Relevant Reading: A microfluidic biochip for complete blood cell counts at the point-of-care

In-Depth [in vitro study]: To collect single cells, the biochip used contactless dielectrophorectic-traps and an array of facing electrodes. When particles were introduced to the chip, each cell experienced negative DEP forces that trapped it in a chamber within the electrical field. Once a cell was trapped in a chamber, no other cells could enter.

To optimize the parameters of the biochip, polystyrene microspheres were put in the chip and subjected to various voltages and signal frequencies to determine their effects on the resulting velocity and DEP force. Flow rates were adjusted to optimize the capture efficiency, with higher flow rates resulting in a 510% drop in the efficiency of capturing the microspheres. These parameters were then validated using a breast adenocarcinoma cell line (MDA-MD-231) and yeast cells.

Cells were isolated from the chip and assessed for viability. A 1.5-fold increase in transformation efficiency was noted in the yeast cells, confirming the safety of this technology. A mixture of MDA-MD-231 cells, yeast cells, and streptavidin-coated polystyrene microspheres was put into the biochip. Because each of these particles have different polarization properties, they could be separated by the biochip. Separation efficiency was found to be 79, 88, and 86% for the breast cancer cells, yeast cells, and microspheres, respectively.

Image: PD

2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

2 Minute Medicines The Classics in Medicine: Summaries of the Landmark Trials is available now in paperback and e-book editions.

This text summarizes the key trials in:General Medicine and Chronic Disease, Cardiology, Critical and Emergent Care, Endocrinology, Gastroenterology, Hematology and Oncology, Imaging, Infectious Disease, Nephrology, Neurology, Pediatrics, Psychiatry, Pulmonology, and Surgery.

See the rest here:
Low-cost biochip isolates cells for clinical diagnosis [PreClinical] - 2 Minute Medicine

Posted in Cell Medicine | Comments Off on Low-cost biochip isolates cells for clinical diagnosis [PreClinical] – 2 Minute Medicine

Israeli Scientists: Stem Cell Therapy Not Good for All Heart Patients – The Jewish Press – JewishPress.com

Posted: June 18, 2017 at 8:41 pm

Photo Credit: Nati Shohat / Flash 90

Patients with severe and end-stage heart failure have few treatment options available to them apart from transplants and miraculous stem cell therapy. But a new Tel Aviv University study has found that stem cell therapy may in fact harm patients with heart disease.

The research, led by Prof. Jonathan Leor of TAUs Sackler Faculty of Medicine and Sheba Medical Center and conducted by TAUs Dr. Nili Naftali-Shani, explores the current practice of using cells from the host patient to repair tissue and contends that this can prove deleterious or toxic for patients. The study was recently published in the journal Circulation.

We found that, contrary to popular belief, tissue stem cells derived from sick hearts do not contribute to heart healing after injury, said Prof. Leor. Furthermore, we found that these cells are affected by the inflammatory environment and develop inflammatory properties. The affected stem cells may even exacerbate damage to the already diseased heart muscle.

Tissue or adult stem cells blank cells that can act as a repair kit for the body by replacing damaged tissue encourage the regeneration of blood vessel cells and new heart muscle tissue. Faced with a worse survival rate than many cancers, a number of patients with heart failure have turned to stem cell therapy as a last resort.

But our findings suggest that stem cells, like any drug, can have adverse effects, said Prof. Leor. We concluded that stem cells used in cardiac therapy should be drawn from healthy donors or be better genetically engineered for the patient.

Hope for improved cardiac stem cell therapy

In addition, the researchers also discovered the molecular pathway involved in the negative interaction between stem cells and the immune system as they isolated stem cells in mouse models of heart disease. After exploring the molecular pathway in mice, the researchers focused on cardiac stem cells in patients with heart disease.

The results could help improve the use of autologous stem cells those drawn from the patients themselves in cardiac therapy, Prof. Leor said.

We showed that the deletion of the gene responsible for this pathway can restore the original therapeutic function of the cells, said Prof. Leor. Our findings determine the potential negative effects of inflammation on stem cell function as theyre currently used. The use of autologous stem cells from patients with heart disease should be modified. Only stem cells from healthy donors or genetically engineered cells should be used in treating cardiac conditions.

The researchers are currently testing a gene editing technique (CRISPER) to inhibit the gene responsible for the negative inflammatory properties of the cardiac stem cells of heart disease patients. We hope our engineered stem cells will be resistant to the negative effects of the immune system, said Prof. Leor.

Meanwhile, for those unable to profit from stem cell therapy, researchers at Ben Gurion University of the Negev (BGU) have developed a revolutionary new drug that may reverse the damage and repair the diseased heart.

The newly developed drug is a polymer which reduces the inflammation in cardiovascular tissue and stops plaque build-up in arteries. Then it goes one step further and removes existing plaque in the heart, leaving healthy tissue behind.

Professor Ayelet David, a researcher at BGU revealed the drug might also help people suffering from diabetes, hypertension and other conditions associated with old age.

Read the original:
Israeli Scientists: Stem Cell Therapy Not Good for All Heart Patients - The Jewish Press - JewishPress.com

Posted in Cell Therapy | Comments Off on Israeli Scientists: Stem Cell Therapy Not Good for All Heart Patients – The Jewish Press – JewishPress.com

Tired of taking pills for diabetes? How about a shot of broccoli? – PBS NewsHour

Posted: June 18, 2017 at 8:40 pm

A compound found in broccoli improves diabetic outcomes to an extent that rivals the go-to drug treatment, according to a new study. Photo by Flickr user LID/Jonas Ingold.

Pills, pills, pills. It seems every ailment from headaches to high blood pressure needs them. But, what if you could swap the medication for vegetables?

An international group of researchers envision such a future for type-2 diabetics based on new results published Wednesday in the journal Science Translational Medicine. Their findings show how a compound found in broccoli improves diabetic outcomes to an extent that rivals the go-to drug treatment, with fewer severe side effects.

To many patients, it might be more attractive to take a broccoli shot or drink than having to take another pill, said Anders Rosengren, at the University of Gothenburg in Sweden and the studys senior author.

Diabetes afflicts more than 400 million people worldwide, four times as many people as in 1980. Part of the problem is the disease can progress unnoticed for years, even decades, until severe complications like compromised kidney function arise.

Its why we need to be so active with this disease so we have the proper treatment at early stages, Rosengren said.

Their project wants to find an alternative for metformin, a gold-standard drug that tackles a hallmark of diabetes: runaway production of glucose in the liver. Insulin normally keeps glucose on a tight leash, but becomes dysregulated in diabetes. Although metformin works well, it has a few problems.

One problem is that it cannot be taken by people with poor kidney function, Rosengren said, yet poor kidney function is one of the most common complications of type-2 diabetes. And metformin can cause side effects including stomach pain, bloating and diarrhea in some patients.

Diabetes is not attributable to one gene, but rather a collection. So Rosengren and his colleagues wanted a drug that could modify a network of diabetes-related genes. A preliminary test, associating a set of 50 liver genes involved in type-2 diabetes and 3,800 drugs, landed on a compound called sulforaphane. Sulforaphane is found in cruciferous vegetables, like broccoli, and has improved insulin responses in diabetic rats in previous studies.

To determine if sulforaphane modifies blood sugar levels, the researchers completed a series of investigations before conducting a human trial.

Early tests showed that sulforaphane could prevent glucose overproduction in liver cells grown in petri dishes. Next, the team tried their luck in rodent models of diabetes. There, they found sulforaphane both prevented the development of glucose intolerance, a hallmark of diabetes, and lowered blood glucose levels as much as metformin did.

Emboldened by these positive results, the researchers recruited 97 type-2 diabetics from Sweden to take daily doses of sulforaphane in the form of a highly concentrated, liquid broccoli sprout extract or a placebo for 12 weeks.

Only the patients who took broccoli extract showed a clear reduction in blood sugar levels.The broccoli extract was most effective for overweight patients with unmanaged type-2 diabetes. Plus, no patients on the broccoli regimen reported severe or lasting side effects during the three-month study.

Alongside the other lifestyle things like physical activity and not eating a whole lot of refined sugars, this could be a promising therapy, said Chris DAdamo, an epidemiologist and healthy lifestyle expert at the University of Maryland School of Medicine, who was not involved in the study. It needs to be replicated, [but] I was positively surprised by the degree of efficacy that it showed and the lack of noticeable side effects.

But before you rush to the grocery store, know that the amount of sulforaphane taken by the patients was approximately 100 times that found naturally in broccoli or the equivalent of consuming 11 pounds of broccoli per day.

Rosengren is encouraged by the results, but advises that people should wait for drug regulators to approve broccoli sprout extract for type-2 diabetes before they rush to try the treatment.

It has the potential to become an important complement to existing treatment options for type-2 diabetes, Rosengren said.

See more here:
Tired of taking pills for diabetes? How about a shot of broccoli? - PBS NewsHour

Posted in Diabetes | Comments Off on Tired of taking pills for diabetes? How about a shot of broccoli? – PBS NewsHour

Diane Abbott back in shadow cabinet after diabetes struggle – BBC News

Posted: June 18, 2017 at 8:40 pm


BBC News
Diane Abbott back in shadow cabinet after diabetes struggle
BBC News
Diane Abbott has returned to her role of shadow home secretary after diabetes led to her missing the end of the general election campaign. Labour leader Jeremy Corbyn said his close ally was back in the shadow cabinet after suffering "a great deal".
Diane Abbott returns to Labour front bench after bout of ill-health ...The Guardian
Diane Abbott now back as Shadow Home Secretary confirms ...The Sun

all 16 news articles »

Read more from the original source:
Diane Abbott back in shadow cabinet after diabetes struggle - BBC News

Posted in Diabetes | Comments Off on Diane Abbott back in shadow cabinet after diabetes struggle – BBC News

Broccoli compound could offer obese diabetics a drug-free way to slash blood sugar levels – New Atlas

Posted: June 18, 2017 at 8:40 pm

If a promising new study lives up to expectations, doctors might soon be prescribing a pill containing an antioxidant found in broccoli to obese patients with Type 2 diabetes (Credit: Margareta Gustafsson Kubista/University of Gothenburg)

Love it or hate it, Swedish scientists have found another reason for you to load up on broccoli, or at least finish what's on your plate. As it turns out, sulforaphane, a powerhouse antioxidant found in the vegetable, could be Nature's secret weapon against type 2 diabetes, offering obese patients a way to slash their blood glucose levels and fight the disease.

This is not the first time sulforaphane has been in the health spotlight. Found in cruciferous greens such as broccoli and cabbage (though if you want to get the most bang for your bite, broccoli sprouts are the way to go), the compound is known for its cancer-fighting and anti-inflammation properties. However hardly anything was known about its effect on type 2 diabetes until now.

NEW ATLAS NEEDS YOUR SUPPORT

Upgrade to a Plus subscription today, and read the site without ads.

It's just US$19 a year.

Type 2 diabetes occurs when the body isn't able to make enough insulin or to use the hormone to regulate blood glucose levels. This causes a build-up of sugar in the blood and for obese patients, their excess body fat makes it harder for the liver and muscle tissue to absorb this excess blood glucose. At present, type 2 diabetes affects more than 300 million people worldwide and makes up 90 percent of all diabetes cases.

While metformin is the industry standard for controlling blood glucose, the drug is not suitable for everyone, in particular those with reduced kidney function, which affects 15 percent of those with the disease. In addition, it has been reported to cause side-effects such as nausea, bloating, abdominal pain, or diarrhea in some 30 percent of patients who take it.

In their search for an alternative therapy, researcher Annika Axelson of the University of Gothenburg and her colleagues decided to use a different tactic. Instead of targeting an individual gene or protein, they focused on identifying the genes responsible for the liver's elevated glucose production, a key disease mechanism. By analyzing the liver tissue of diabetic mice that had been fed a high-fat diet, they eventually identified a network of 50 genes responsible for causing increased blood glucose levels. This was then matched against different compounds for drugs that could potentially reverse the disease.

Of the 2,800 substances that they investigated, one stood out: sulforaphane. Researchers were alerted to its potential impact on diabetes when they found it tamping down glucose production in cultured liver cells.

When tested in rodents with dietary-induced diabetes, the researchers found that their blood sugar dropped by 23 percent in four weeks when they were given the compound, which was comparable to the 24 percent drop in those that were given metformin. To ensure sulforaphane was directly responsible for this change, they removed it from the extract to see what would happen, and as co-author Anders Rosengren notes, the effect disappeared.

"We also looked at the genes from the liver of the animals and saw that the 50 key genes had been changed in the right direction," he adds.

Encouraged by the results, they tested it on people next. The 12-week randomized placebo-controlled study involved 97 type 2 diabetes patients who were given a powdered broccoli sprout extract containing 100 times the amount of sulforaphane found naturally in broccoli. All, with the exception of three, were also on metformin. Given what they had seen in the animal experiments, the researchers report that it was "not surprising" that sulforaphane had the greatest impact on obese participants with dysregulated diabetes, whose glucose levels decreased significantly while fasting enough to meet the 7 percent goal recommended by the American Diabetes Association.

That said, while sulforaphane might seem like a miracle worker, there is a limit to what it can do on its own. When rats were fed a high-fructose diet with a 60 percent fat content, the researchers found that even though it had positive side effects, the diet was "too severe a stressor to fully prevent glucose intolerance." In addition, as the researchers note in the study, the extract "did not change body weight, BMI, liver parameters, cholesterol concentration, plasma triglycerides, or blood hemoglobin concentration [in obese human patients.]" In other words, patients will also need to adopt appropriate lifestyle habits to get the most out of the therapy. As numerous studies have shown, diet and an active lifestyle are key to preventing and reversing the disease.

Moving forward, the researchers will continue to study the potential of broccoli sprouts extract as an alternative drug treatment. In addition, since all the participants involved in the study were Scandinavian, more data is also needed to document its impact on other groups of patients, such as those with pre-diabetes.

"High doses of BSE cannot yet be recommended to patients as a drug treatment but would require further studies, including data on which groups of patients would potentially benefit most from it," note the authors.

If all goes well, the researchers say the plan is to bring the broccoli sprout extract to market within two years and there's a good reason it would be better as a pill. To experience the benefits reported in the study, a person with diabetes would need to eat four to five kilograms (8.8 to 11 pounds) of broccoli a day.

That said, manufacturers of metformin need not worry. Rather than see it as a competitor, the researchers regard sulforaphane as a "supplement to existing medication." Metformin works by decreasing the amount of glucose that the liver releases into the blood stream and also makes cells more receptive to insulin. Sulforaphane, on the other hand, stops the liver enzymes from over-producing glucose and also has the advantage of having mild side-effects, thus offering those who can't take metformin a viable alternative. As a naturally occurring compound, it could also have other benefits.

"As functional food, it can reach the patients faster than a medication, and it is also an interesting concept from a diabetes perspective where diet is central," says Rosengren.

The study was published in Science Translational Medicine.

Source: Lund University

Read the original:
Broccoli compound could offer obese diabetics a drug-free way to slash blood sugar levels - New Atlas

Posted in Diabetes | Comments Off on Broccoli compound could offer obese diabetics a drug-free way to slash blood sugar levels – New Atlas

‘Animal House’ actor Stephen Furst dies from diabetes complications – ABC15 Arizona

Posted: June 18, 2017 at 8:40 pm

Heat Advisoryissued June 18 at 2:48PM MST expiring June 22 at 8:00PM MST in effect for: Apache, Coconino, Navajo, Yavapai

Excessive Heat Warningissued June 18 at 2:48PM MST expiring June 22 at 8:00PM MST in effect for: Coconino, Gila, Yavapai

Excessive Heat Warningissued June 18 at 2:48PM MST expiring June 22 at 8:00PM MST in effect for: Coconino

Excessive Heat Warningissued June 17 at 3:01PM MST expiring June 22 at 8:00PM MST in effect for: Coconino, Gila, Yavapai

Heat Advisoryissued June 17 at 3:01PM MST expiring June 22 at 8:00PM MST in effect for: Yavapai

Heat Advisoryissued June 17 at 3:01PM MST expiring June 22 at 8:00PM MST in effect for: Apache, Coconino, Navajo

Excessive Heat Warningissued June 17 at 2:15AM MST expiring June 22 at 8:00PM MST in effect for: Coconino

Excessive Heat Warningissued June 17 at 2:15AM MST expiring June 22 at 8:00PM MST in effect for: Coconino

Excessive Heat Warningissued June 14 at 2:52PM MST expiring June 20 at 8:00PM MST in effect for: Gila, Yavapai

Excessive Heat Warningissued June 14 at 2:52PM MST expiring June 20 at 8:00PM MST in effect for: Coconino, Yavapai

Excessive Heat Watchissued June 14 at 3:18AM MST expiring June 20 at 8:00PM MST in effect for: Coconino, Gila, Yavapai

Here is the original post:
'Animal House' actor Stephen Furst dies from diabetes complications - ABC15 Arizona

Posted in Diabetes | Comments Off on ‘Animal House’ actor Stephen Furst dies from diabetes complications – ABC15 Arizona

Glow Run fundraiser set for Childhood Diabetes Expense Relief Fund – American Press

Posted: June 18, 2017 at 8:40 pm

JENNINGS The Childhood Diabetes Expense Relief Fund will hold its annual Glow Run on da Bayou 7-10 p.m. Saturday, June 24, at the baseball fields at 1206 East Academy Ave.

The goal of the run, which last year drew over 200 runners and 150 spectators, is to raise money to help families of children with Type 1 diabetes buy insulin and testing supplies and meet other medical needs, said Casey Doucet, local CDERF president.

We hope to see over 500 people this year and would love to see our participants count break the 300 mark. Doucet said. Our main goal, however, is to educate and bring awareness to people locally and have a blast while doing so.

Doucet and his wife, Monique, created CDERF after their son, Wyatt, was diagnosed with Type 1 diabetes in February 2014 at the age of 3.

We had no idea the struggles that we would be facing just trying to keep him alive day after day. After six months of the daily stresses involved with treating our child with this disease, the bills began to roll in, Doucet said.

On top of all the things weve had to deal with, we now had to choose which bill wasnt getting paid this month due to the cost of diabetesrelated medications and supplies. These supplies are literally a matter of life and death, so you do not have the option of not getting them.

The Doucets began discussing ways to help other families facing the same issues, and they hit on the idea of forming the group.

It is our goal that other families do not have to face these circumstances, Doucet said. We feel like if this is the path we are meant to take with Wyatt, then we want to help others who are also facing these difficulties.

The Glow Run is not the main fundraiser for the group, but it is the main public outreach effort, he said.

It allows us to meet people in this area and helps us to raise awareness of this awful disease, Doucet said.

During last years Glow Run, we met several local families who had Type 1 diabetic children. We have been able to help several of them financially, as well as with advice or just an understanding listening ear.

The run will start at the west entrance of the Jennings Park and Recreation parking lot and travel east on East Academy, turning right onto River Oak Drive, circling the subdivision and retracing the route to the starting line.

Registration is available atcderf.org/glowrunthrough midnight June 23 and 5-6 p.m. in the park on race day.

Entry fees are $25 for adults; $20 for children 12-17; $15 for children 7-11; and $10 for non-participants. Children 6 and under enter free.

Awards will be presented to the top three runners in each division, as well as the top male and female in each age group.

Early registrants who sign up before midnight on June 20 will receive a T-shirt, glow items and a water bottle. Participants may also bring their own glow items.

Food and drinks will be provided for all paid participants. Spectators can buy a $10 wristband and eat. Children 6 and under will eat and drink free.

For more information, call CDERF at 337-329-1372 or emailinfo@cderf.org.

Read the rest here:
Glow Run fundraiser set for Childhood Diabetes Expense Relief Fund - American Press

Posted in Diabetes | Comments Off on Glow Run fundraiser set for Childhood Diabetes Expense Relief Fund – American Press

Sherborn’s Jillian Tierney shows how she deals with diabetes – Wicked Local Acton

Posted: June 18, 2017 at 8:40 pm

Ten-year-old Sherborn resident Jillian Tierney was diagnosed with type 1 diabetes in August 2016; when faced with the decision of which charitable organization she would highlight for her fifth-grade Citizenship Project, Tierney chose Joslin Diabetes Center, where she receives her care from Dr. Anat Hanono.

Ten-year-old Sherborn resident Jillian Tierney was diagnosed with type 1 diabetes in August 2016; when faced with the decision of which charitable organization she would highlight for her fifth-grade Citizenship Project, Tierney chose Joslin Diabetes Center, where she receives her care from Dr. Anat Hanono.

Dr. Peter Amenta, president and CEO of Joslin Diabetes Center, joined Jillian and her family at Pine Hill Elementary School for the fifth-grade expo on June 7, where she debuted her project. Tierney showed Amenta her diabetes kit and demonstrated how she uses her glucose monitor, answered questions on the importance of counting carbs, and offered up information and statistics on diabetes for the parents and friends in attendance.

Joslins pediatrics department encourages and allows for young patients to continue pursuing their goals and participating in normal activities as part of learning to incorporate diabetes into their everyday life, and Tierney does not let her recent diagnosis slow her down. She plays soccer, recently finished a spring production of Mulan at a local theater company and will attend coastal ecology camp and a diabetes camp this summer.

For more information, visit http://www.joslin.org.

Here is the original post:
Sherborn's Jillian Tierney shows how she deals with diabetes - Wicked Local Acton

Posted in Diabetes | Comments Off on Sherborn’s Jillian Tierney shows how she deals with diabetes – Wicked Local Acton

Page 1,537«..1020..1,5361,5371,5381,539..1,5501,560..»